Bear discusses studies adding treatments to chemotherapy in order to increase the pathological complete response (pCR) rate and the difficulties of translating those benefits into better overall survival (OS) rates for patients with breast cancer.
Harry Bear, MD, PhD
Articles by Harry Bear, MD, PhD
